Clínic Barcelona commemorates World Breast Cancer Day with a conference focused on patients’ wellbeing
The event addressed emotional, sexual, bureaucratic and research-related aspects, with a multidisciplinary and participatory approach.
News from Institute of Cancer and Blood Diseases
An experimental new CAR-T therapy shows high efficacy in multiple myeloma, even against treatment resistance
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrat...
Hospital Clínic ranks among the world’s best smart and specialized hospitals according to Newsweek
Hospital Clínic Barcelona appears once again in the two main rankings published by Newsweek alongside Statista. The hospital features in eleven spe...
Apheresis: donation and therapeutic use
Apheresis is a medical procedure by which specific components of a person’s blood are removed and the rest is returned to the bloodstream through o...
A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
A multicenter study identifies the differentiated risk of colorectal cancer depending on the affected gene in Lynch syndrome
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic m...
Clínic Barcelona Comprehensive Cancer Center appoints new heads of the Medical Oncology and Hematology departments to strengthen clinical and scientific developmen
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona, has announce...
New study validates the prognostic value of the HER2DX test in HER2-positive breast cancer
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—tog...
The Clínic Barcelona Comprehensive Cancer Center presents its latest advances at the ASCO 2025 Global Oncology Congress
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic, IDIBAPS, and the University of Barcelona, strengthens its intern...
Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated
Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regul...